Biggest News Aggregation in the World
📰 Nasdaq Ndra News

Page 2 - Nasdaq Ndra News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Nasdaq Ndra. Real-time updates on events, politics, business and more.

ENDRA Life Sciences Inc. (NASDAQ:NDRA) Sees Large Decline in Short Interest

ENDRA Life Sciences Inc. (NASDAQ:NDRA – Get Rating) saw a large drop in short interest in May. As of May 15th, there was short interest totalling 249,100 shares, a drop of 86.9% from the April 30th total of 1,900,000 shares. Based on an average daily volume of 2,730,000 shares, the short-interest ratio is currently 0.1 […]
Morgan Stanley Geode Capital Management Virtu Financial Zacks Investment Research Endra Life Sciences Inc Renaissance Technologies

Zacks: Brokerages Anticipate ENDRA Life Sciences Inc. (NASDAQ:NDRA) to Post -$0.07 Earnings Per Share

Equities analysts expect ENDRA Life Sciences Inc. (NASDAQ:NDRA – Get Rating) to post earnings of ($0.07) per share for the current quarter, Zacks Investment Research reports. Zero analysts have made estimates for ENDRA Life Sciences’ earnings. ENDRA Life Sciences posted earnings of ($0.06) per share in the same quarter last year, which indicates a negative […]
Thomson Reuter Geode Capital Management Life Sciences Get Rating Virtu Financial Zacks Investment Research Renaissance Technologies

ENDRA Life Sciences (NASDAQ:NDRA) Upgraded to Hold at Zacks Investment Research

ENDRA Life Sciences (NASDAQ:NDRA – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued to investors on Friday, Zacks.com reports. According to Zacks, “ENDRA Life Sciences Inc. is a developer of enhanced ultrasound technologies. ENDRA Life Sciences Inc. is based in Ann Arbor, […]
United States Morgan Stanley Endra Life Sciences Geode Capital Management Life Sciences Get Rating Zacks Investment Research

ENDRA Life Sciences (NASDAQ:NDRA) Announces Quarterly Earnings Results

ENDRA Life Sciences (NASDAQ:NDRA – Get Rating) posted its quarterly earnings results on Wednesday. The company reported ($0.08) earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of ($0.08), Fidelity Earnings reports. During the same quarter in the previous year, the firm posted ($0.10) earnings per share. Shares of ENDRA Life Sciences […]
Morgan Stanley Endra Life Sciences Life Sciences Get Rating Virtu Financial Zacks Investment Research Renaissance Technologies

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science